Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3295679 | Gastroenterology | 2011 | 13 Pages |
Abstract
Deferasirox treatment for 3 or more years reversed or stabilized liver fibrosis in 83% of patients with iron-overloaded β-thalassemia. This therapeutic effect was independent of reduced concentration of liver iron (defined by the response criteria) or previous exposure to hepatitis C virus.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Yves Deugnier, Bruno Turlin, Martine Ropert, M. Domenica Cappellini, John B. Porter, Vanessa Giannone, Yiyun Zhang, Louis Griffel, Pierre Brissot,